Close X

We've changed the way you complete courses

In response to user feedback we have simplified the way courses can be completed.

Until now you needed to complete the topics and modules in order, from start to finish. But from today you can complete them in any order you wish.

Just visit any topic that interests you, and when you are ready mark it as completed by clicking the green 'Mark complete' button at the bottom of the page.

Once you have completed all of the topics in a module an assessment will be provided for you.

Complete all the assessments to finish the course.

Thanks, I've got it! X

Welcome to the SGLT-2 inhibitors course

SGLT-2 inhibitors are one of the newest classes of drug in the diabetes armamentarium. The first module in this course looks at their history and, through animation, allows you to focus on the physiology and inhibition of renal glucose absorption. The second module builds on this knowledge, allowing you to assess the key trial data to date for empagliflozin, dapagliflozin and canagliflozin. Module 3 compares and contrasts the EMPA-REG OUTCOME and CANVAS Program studies with particular emphasis on cardiovascular outcomes. Module 4 looks at the newer possibilities of this drug class as an adjunct therapy to insulin in type 1 diabetes and highlights the important safety issue of diabetic ketoacidosis. Module 5 focuses on the renal outcomes of major SGLT-2 trials, with particular emphasis on the results of the CREDENCE trial. Module 6 delves deeper into cardiovascular outcomes from SGLT-2 trials, comparing these with results from the large-scale cardiovascular outcomes trial, DECLARE-TIMI 58. In Module 7 we host an international round-table discussion of ‘tips and tricks’ for the use of SGLT-1/-2 inhibitors in type 1 diabetes from leading experts in the field. Module 8 reports further results from cardiovascular outcome trials, this time from the VERTIS CV trial, which investigated the effects of ertugliflozin. Further trial results are reported in module 9, this time on the latest renal outcomes from studies of SGLT-2 inhibitors.

Course Content

How to complete one of our courses

Once enrolled on a course, you can access the content in any order you wish. Having started a module, you can browse the contents using the ‘CONTENT AND YOUR PROGRESS’ table on the left side of the page. In order to complete the module you need to click the Complete button displayed at the bottom of each topic page.

There is a marked assessment at the end of each module. To gain access to the assessment, all topic pages need to have been marked complete.

If at any time you need help, wish to contact us or provide feedback, access the toolbar to the right of the screen and a number of options will appear.